SEC Company Response from NANOVIRICIDES, (NNVC) — Jun 11, 2026
NANOVIRICIDES, INC.
Date: June 11, 2026 · CIK: 0001379006 · Accession: 0001104659-26-072869
AI Filing Summary & Sentiment
File numbers found in text: 333-296550
Show Raw Text
CORRESP 1 filename1.htm NANOVIRICIDES, INC. 1 Controls Drive Shelton, Connecticut 06484 June 11, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade and Services 100 F Street, N.E. Washington, D.C. 20549 Re: NanoViricides, Inc. Registration Statement on Form S-3 Filed June 5, 2026 File No. 333-296550 REQUEST FOR ACCELERATION OF EFFECTIVENESS Requested Date: Monday, June 15, 2026 Requested Time: 4:30 p.m., Eastern Time Ladies and Gentlemen, Pursuant to Rule 461 under the Securities Act of 1933, as amended, NanoViricides, Inc. (the "Company"), hereby requests acceleration of effectiveness of the above referenced Registration Statement on Form S-3 (File Number 333-296550), as amended so that it will become effective at 4:30 p.m., Eastern Time, on Monday, June 15, 2026, or as soon as practicable thereafter. Please contact our counsel, Peter Campitiello, Esq. of Lucosky Brookman LLP at (646) 242-7536 with any questions you may have regarding this request. In addition, the Company requests that you kindly notify Mr. Campitiello by telephone when this request for acceleration has been granted Very truly yours, /s/ Anil Diwan Anil Diwan President, Chief Executive Officer, and Chairman